Geojit's research report on Narayana Hrudayalaya
Narayana Health Ltd (NH) is a chain of multi-specialty hospitals operating in India and the Cayman Islands. NH reported 9MFY23 revenue of Rs. 3,303cr (+20% YoY) from Rs.2,760cr in 9MFY22 driven by higher momentum in both Indian and Cayman businesses. The company registered an EBITDA of Rs.690 cr from Rs. 478cr in 9MFY22 with an EBITDA margin of 20.9% (up 360 bps YoY) on account of improvement in payor mix and cost efficiency. Resultantly, PAT grew 59% YoY to Rs.434 cr. The unit at Cayman Island reported revenues at $80mn (18% YoY) for the nine month period due to lifting of restrictions. The recently acquired orthopaedic hospital, Sparsh, began operations in October 2022 and generated 30% EBITDA for the quarter. We expect the growth to continue on the back of increased patient footfall, rising Average Revenue Per Operating Bed (ARPOB) and the aggressive capex plan for both organic and inorganic expansion.
Outlook
Hence we reiterate our “Accumulate” rating based on 17x FY25E EV/ EBITDA with a target price of Rs.911.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
